Dare Bioscience, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Dare Bioscience, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Dare Bioscience, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $14K, a 98.9% decline year-over-year.
  • Dare Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $15.6M, a 1064% increase from 2022.
  • Dare Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.34M, a 98.2% decline from 2021.
  • Dare Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $75.8M, a 202% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $15.6M +$14.3M +1064% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $1.34M -$74.5M -98.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $75.8M +$50.7M +202% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $25.1M +$20M +388% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $5.15M -$4.96M -49.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $10.1M +$9.96M +6424% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $155K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.